Drug Makers File With European Medicines Agency For Regulatory Approval Of Investigational Ebola Vaccine; WHO Notes Fluctuating Pattern Of Disease Transmission In DRC Outbreak

CIDRAP News: European regulators consider 2nd Ebola vaccine
“Bavarian Nordic [Thursday] announced that it and its partner Janssen Pharmaceuticals, part of Johnson & Johnson, have submitted an application to the European Medicines Agency (EMA) for approval of their investigational two-dose Ebola vaccine regimen. The news comes as one new Ebola case was reported [Thursday] in the Democratic Republic of the Congo (DRC) outbreak, part of a fluctuating pattern that the World Health Organization (WHO) noted [Thursday] in its weekly snapshot of the event…” (Schnirring, 11/7).